United States · FDA National Drug Code directory
Influenzinum 200C
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 44911-0736_f35cb424-00be-4b9b-9c6b-33720ab6b578
- Product NDC
- 44911-0736
- Form
- LIQUID
- Composition / generic term
- Influenzinum (2024-2025)
- Labeler
- Energique, Inc.
- Marketing category
- UNAPPROVED HOMEOPATHIC
- Marketing start / end (source format)
- 20250418 / 20300305
Source-listed ingredients
- INFLUENZA A VIRUS A/VICTORIA/4897/2022 IVR-238 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED) — 200 [hp_C]/mL
- INFLUENZA A VIRUS A/THAILAND/8/2022 IVR-237 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED) — 200 [hp_C]/mL
- INFLUENZA B VIRUS B/AUSTRIA/1359417/2021 BVR-26 WHOLE — 200 [hp_C]/mL
- INFLUENZA B VIRUS B/PHUKET/3073/2013 BVR-1B WHOLE — 200 [hp_C]/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 30 mL in 1 BOTTLE, DROPPER (44911-0736-1) · 44911-0736-1
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →